Suzanne T. Thomas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Suzanne T. Thomas has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Joseph P. Noel
Jack H. Skirball Center for Chemical Biology and Proteomics, The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, California 92037, United States
2 shared publications - Gordon Louie
Salk Institute for Biological Studies and Howard Hughes Medical Institute, University of California San Diego, La Jolla, California 92093, United States
1 shared publication - James J. La Clair
Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0358, USA
1 shared publication - Johnathan W. Lubin
Salk Institute for Biological Studies and Division of Biological Sciences, University of California San Diego, La Jolla, California 92093, United States
1 shared publication Victoria Lundblad
Salk Institute for Biological Studies and Division of Biological Sciences, University of California San Diego, La Jolla, California 92093, United States
1 shared publication- Yongsoon Shin
Pacific Northwest National Laboratory, Richland, Washington, United States
1 shared publication
Latest Publications
- Open Access
- 27 April 2021
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 11 (26) , 15512-15518
Plant-based CO2 drawdown and storage as SiC
This study demonstrates how integration of plants into an artificial carbon cycle is capable of harmoniously operating with Earth's natural cycles as one means to recycle atmospheric CO2 for economically lucrative green materials.
- 27 April 2021
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 11 (26) , 15512-15518
Open AccessPlant-based CO2 drawdown and storage as SiC
This study demonstrates how integration of plants into an artificial carbon cycle is capable of harmoniously operating with Earth's natural cycles as one means to recycle atmospheric CO2 for economically lucrative green materials.
- 3 July 2019
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 14 (8) , 1767-1779
Substrate Specificity and Engineering of Mevalonate 5-Phosphate Decarboxylase
A bifurcation of the mevalonate (MVA) pathway was recently discovered in bacteria of the Chloroflexi phylum. In this alternative route for the biosynthesis of isopentenylpyrophosphate (IPP), the penultimate step is the decarboxylation of (R)-mevalonate 5-phosphate ((R)-MVAP) to isopentenyl phosphate (IP), which is followed by the ATP-dependent phosphorylation of IP to IPP catalyzed by isopentenyl phosphate kinase (IPK). Notably, the decarboxylation reaction is catalyzed by mevalonate 5-phosphate decarboxylase (MPD), which shares considerable sequence similarity with mevalonate diphosphate decarboxylase (MDD) of the classical MVA pathway. We show that an enzyme originally annotated as an MDD from the Chloroflexi bacterium Anaerolinea thermophila possesses equal catalytic efficiency for (R)-MVAP and (R)-mevalonate 5-diphosphate ((R)-MVAPP). Further, the molecular basis for this dual specificity is revealed by near atomic-resolution X-ray crystal structures of A. thermophila MPD/MDD bound to (R)-MVAP or (R)-MVAPP. These findings, when combined with sequence and structural comparisons of this bacterial enzyme, functional MDDs, and several putative MPDs, delineate key active-site residues that confer substrate specificity and functionally distinguish MPD and MDD enzyme-classes. Extensive sequence analyses identified functional MPDs in the halobacteria class of archaea that had been annotated as MDDs. Finally, no eukaryotic MPD candidates were identified, suggesting the absence of the alternative MVA (altMVA) pathway in all eukaryotes, including, paradoxically plants, which universally encode a structural and functional homolog of IPK. Additionally, we have developed a viable engineered strain of Saccharomyces cerevisiae as an in vivo metabolic model and a synthetic biology platform for enzyme engineering and terpene biosynthesis in which the classical MVA pathway has been replaced with the altMVA pathway.
- 3 July 2019
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 14 (8) , 1767-1779
Substrate Specificity and Engineering of Mevalonate 5-Phosphate Decarboxylase
A bifurcation of the mevalonate (MVA) pathway was recently discovered in bacteria of the Chloroflexi phylum. In this alternative route for the biosynthesis of isopentenylpyrophosphate (IPP), the penultimate step is the decarboxylation of (R)-mevalonate 5-phosphate ((R)-MVAP) to isopentenyl phosphate (IP), which is followed by the ATP-dependent phosphorylation of IP to IPP catalyzed by isopentenyl phosphate kinase (IPK). Notably, the decarboxylation reaction is catalyzed by mevalonate 5-phosphate decarboxylase (MPD), which shares considerable sequence similarity with mevalonate diphosphate decarboxylase (MDD) of the classical MVA pathway. We show that an enzyme originally annotated as an MDD from the Chloroflexi bacterium Anaerolinea thermophila possesses equal catalytic efficiency for (R)-MVAP and (R)-mevalonate 5-diphosphate ((R)-MVAPP). Further, the molecular basis for this dual specificity is revealed by near atomic-resolution X-ray crystal structures of A. thermophila MPD/MDD bound to (R)-MVAP or (R)-MVAPP. These findings, when combined with sequence and structural comparisons of this bacterial enzyme, functional MDDs, and several putative MPDs, delineate key active-site residues that confer substrate specificity and functionally distinguish MPD and MDD enzyme-classes. Extensive sequence analyses identified functional MPDs in the halobacteria class of archaea that had been annotated as MDDs. Finally, no eukaryotic MPD candidates were identified, suggesting the absence of the alternative MVA (altMVA) pathway in all eukaryotes, including, paradoxically plants, which universally encode a structural and functional homolog of IPK. Additionally, we have developed a viable engineered strain of Saccharomyces cerevisiae as an in vivo metabolic model and a synthetic biology platform for enzyme engineering and terpene biosynthesis in which the classical MVA pathway has been replaced with the altMVA pathway.